Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for investment professionals · Thursday, March 28, 2024 · 699,544,192 Articles · 3+ Million Readers

Investor Expectations to Drive Momentum within Materialise NV, Southern First Bancshares, Ensco plc, Corbus Pharmaceuticals, TCP Capital, and Horizon Pharma Public — Discovering Underlying Factors of Influence

NEW YORK, Aug. 21, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Materialise NV (NASDAQ:MTLS), Southern First Bancshares, Inc. (NASDAQ:SFST), Ensco plc (NYSE:ESV), Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), TCP Capital Corp. (NASDAQ:TCPC), and Horizon Pharma Public Limited Company (NASDAQ:HZNP), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

MTLS DOWNLOAD: http://Fundamental-Markets.com/register/?so=MTLS
SFST DOWNLOAD:
http://Fundamental-Markets.com/register/?so=SFST
ESV DOWNLOAD:
http://Fundamental-Markets.com/register/?so=ESV
CRBP DOWNLOAD:
http://Fundamental-Markets.com/register/?so=CRBP
TCPC DOWNLOAD:
http://Fundamental-Markets.com/register/?so=TCPC
HZNP DOWNLOAD:
http://Fundamental-Markets.com/register/?so=HZNP

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Materialise NV (NASDAQ:MTLS), Southern First Bancshares, Inc. (NASDAQ:SFST), Ensco plc (NYSE:ESV), Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), TCP Capital Corp. (NASDAQ:TCPC), and Horizon Pharma Public Limited Company (NASDAQ:HZNP) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed August 17th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

MATERIALISE NV (MTLS) REPORT OVERVIEW

Materialise NV's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Materialise NV reported revenue of $53.76MM vs $38.36MM (up 40.15%) and basic earnings per share $0.01 vs -$0.02. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Materialise NV reported revenue of $161.15MM vs $126.68MM (up 27.21%) and basic earnings per share -$0.03 vs -$0.07. Materialise NV is expected to report earnings on November 8th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.04. The estimated EPS forecast for the next fiscal year is $0.25 and is expected to report on March 5th, 2019.

To read the full Materialise NV (MTLS) report, download it here: http://Fundamental-Markets.com/register/?so=MTLS

-----------------------------------------

SOUTHERN FIRST BANCSHARES, INC. (SFST) REPORT OVERVIEW

Southern First Bancshares' Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Southern First Bancshares reported interest income of $18.54MM vs $14.93MM (up 24.14%) and basic earnings per share $0.75 vs $0.52 (up 44.23%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Southern First Bancshares reported interest income of $61.21MM vs $51.19MM (up 19.57%) and basic earnings per share $1.86 vs $2.06 (down 9.71%). Southern First Bancshares is expected to report earnings on August 21st, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.49.

To read the full Southern First Bancshares, Inc. (SFST) report, download it here: http://Fundamental-Markets.com/register/?so=SFST

-----------------------------------------

ENSCO PLC (ESV) REPORT OVERVIEW

Ensco plc's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Ensco plc reported revenue of $458.50MM vs $457.50MM (up 0.22%) and basic earnings per share -$0.35 vs -$0.15. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Ensco plc reported revenue of $1,843.00MM vs $2,776.40MM (down 33.62%) and basic earnings per share -$0.91 vs $3.13. Ensco plc is expected to report earnings on October 24th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.05. The estimated EPS forecast for the next fiscal year is -$1.16 and is expected to report on February 25th, 2019.

To read the full Ensco plc (ESV) report, download it here: http://Fundamental-Markets.com/register/?so=ESV

-----------------------------------------

CORBUS PHARMACEUTICALS HOLDINGS, INC. (CRBP) REPORT OVERVIEW

Corbus Pharmaceuticals' Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Corbus Pharmaceuticals reported revenue of $0.85MM vs $0.35MM (up 143.75%) and basic earnings per share -$0.21 vs -$0.15. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Corbus Pharmaceuticals reported revenue of $2.44MM vs $1.91MM (up 27.67%) and basic earnings per share -$0.65 vs -$0.49. Corbus Pharmaceuticals is expected to report earnings on November 14th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.14. The estimated EPS forecast for the next fiscal year is -$0.94 and is expected to report on March 11th, 2019.

To read the full Corbus Pharmaceuticals Holdings, Inc. (CRBP) report, download it here: http://Fundamental-Markets.com/register/?so=CRBP

-----------------------------------------

TCP CAPITAL CORP. (TCPC) REPORT OVERVIEW

TCP Capital's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, TCP Capital reported revenue of $48.42MM vs $46.23MM (up 4.74%) and basic earnings per share $0.07 vs $0.35 (down 80.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, TCP Capital reported revenue of $175.97MM vs $148.18MM (up 18.75%) and basic earnings per share $1.19 vs $1.50 (down 20.67%). TCP Capital is expected to report earnings on November 6th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.38. The estimated EPS forecast for the next fiscal year is $1.60 and is expected to report on February 26th, 2019.

To read the full TCP Capital Corp. (TCPC) report, download it here: http://Fundamental-Markets.com/register/?so=TCPC

-----------------------------------------

HORIZON PHARMA PUBLIC LIMITED COMPANY (HZNP) REPORT OVERVIEW

Horizon Pharma Public's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Horizon Pharma Public reported revenue of $302.84MM vs $289.51MM (up 4.60%) and basic earnings per share -$0.20 vs -$1.29. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Horizon Pharma Public reported revenue of $1,056.23MM vs $981.12MM (up 7.66%) and basic earnings per share -$2.52 vs -$1.04. Horizon Pharma Public is expected to report earnings on November 5th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.26. The estimated EPS forecast for the next fiscal year is $1.86 and is expected to report on February 27th, 2019.

To read the full Horizon Pharma Public Limited Company (HZNP) report, download it here: http://Fundamental-Markets.com/register/?so=HZNP

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Powered by EIN News


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release